Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Regulation of immunity by lysosphingolipids and their G protein–coupled receptors
Edward J. Goetzl, Hugh Rosen
Edward J. Goetzl, Hugh Rosen
Published December 1, 2004
Citation Information: J Clin Invest. 2004;114(11):1531-1537. https://doi.org/10.1172/JCI23704.
View: Text | PDF
Review

Regulation of immunity by lysosphingolipids and their G protein–coupled receptors

  • Text
  • PDF
Abstract

T and B lymphocytes, as well as endothelial cells, express distinctive profiles of G protein–coupled receptors for sphingosine 1–phosphate, which is a major regulator of T cell development, B and T cell recirculation, tissue homing patterns, and chemotactic responses to chemokines. The capacity of drugs that act on type 1 sphingosine 1–phosphate receptors to suppress organ graft rejection in humans and autoimmunity in animal models without apparent impairment of host defenses against infections suggests that this system is a promising target for new forms of immunotherapy.

Authors

Edward J. Goetzl, Hugh Rosen

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Control of lymphocyte development and traffic by S1P and S1P1. (A) Thymu...
Control of lymphocyte development and traffic by S1P and S1P1. (A) Thymus. CD4_CD8_ thymocytes develop into “double-positive” CD4+CD8+ thymocytes in the cortex; at the corticomedullary junction, these differentiate into CD4+ helper/inducer T cell precursors or CD8+ suppressor/cytotoxic T cell precursors, which first express fully functional S1P1 GPCRs. S1P in venous sinuses stimulates movement of CD4+ and CD8+ T cells out of the thymus and into the circulation. Dashed arrows show chemotaxis. (B) Lymph nodes. Plasma concentrations of S1P in the HEVs signal through S1P1, causing significant inhibition of T cell chemotaxis (green arrow) to chemokines such as CCL21, which attracts T cells through CCR7 receptors into the lymph node. T cell activation, through the T cell antigen receptor or by endotoxin, downregulates S1P1 GPCRs, decreases inhibition of chemotaxis, and thereby promotes chemotactic responses to chemokines with a consequent increase in T cell influx into lymph nodes. In the lymph node, T cells downregulate chemokine receptors and respond chemotactically through S1P1 GPCRs to the concentration gradient of S1P from the lymph node to efferent lymph, with subsequent efflux from the lymph node and reentry into the blood. Dashed arrows show chemotaxis. S1P1 and CCR7 are both GPCRs. (C) Spleen. The white pulp of the spleen, which contains T and B cells, surrounds central arterioles coursing from trabecular arteries to veins. As shown in the cross-section of white pulp, T cells are localized principally in the periarteriolar lymphoid sheath, but B cells are distributed in the germinal center, B cell corona above the germinal center, and marginal zone, where they are more quickly and completely exposed to blood-borne factors. Of all B cell locations, the concentration of S1P is predicted to be highest in the marginal zone, where it signals inhibition of B cell chemotaxis (green arrow) to the chemokine CXCL13 through its GPCR CXCR5.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts